Literature DB >> 15051624

Thromboxane receptor stimulation associated with loss of SKCa activity and reduced EDHF responses in the rat isolated mesenteric artery.

G J Crane1, C J Garland.   

Abstract

1. The possibility that thromboxane (TXA(2)) receptor stimulation causes differential block of the SK(Ca) and IK(Ca) channels which underlie EDHF-mediated vascular smooth muscle hyperpolarization and relaxation was investigated in the rat isolated mesenteric artery. 2. Acetylcholine (30 nm-3 microm ACh) or cyclopiazonic acid (10 microm CPA, SERCA inhibitor) were used to stimulate EDHF-evoked smooth muscle hyperpolarization. In each case, this led to maximal hyperpolarization of around 20 mV, which was sensitive to block with 50 nm apamin and abolished by repeated stimulation of mesenteric arteries with the thromboxane mimetic, U46619 (30 nm-0.1 microm), but not the alpha(1)-adrenoceptor agonist phenylephrine (PE). 3. The ability of U46619 to abolish EDHF-evoked smooth muscle hyperpolarization was prevented by prior exposure of mesenteric arteries to the TXA(2) receptor antagonist 1 microm SQ29548. 4. Similar-sized smooth muscle hyperpolarization evoked with the SK(Ca) activator 100 microm riluzole was also abolished by prior stimulation with U46619, while direct muscle hyperpolarization in response to either levcromakalim (1 microm, K(ATP) activator) or NS1619 (40 microm, BK(Ca) activator) was unaffected. 5. During smooth muscle contraction and depolarization to either PE or U46619, ACh evoked concentration-dependent hyperpolarization (to -67 mV) and complete relaxation. These responses were well maintained during repeated stimulation with PE, but with U46619 there was a progressive decline, so that during a third exposure to U46619 maximum hyperpolarization only reached -52 mV and relaxation was reduced by 20%. This relaxation could now be blocked with charybdotoxin alone. The latter responses could be mimicked with 300 microm 1-EBIO (IK(Ca) activator), an action not modified by exposure to U46619. 6. An early consequence of TXA(2) receptor stimulation is a reduction in the arterial hyperpolarization and relaxation attributed to EDHF. This effect appears to reflect a loss of SK(Ca) activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051624      PMCID: PMC1574933          DOI: 10.1038/sj.bjp.0705756

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Inhibition of endothelial cell migration, intercellular communication, and vascular tube formation by thromboxane A(2).

Authors:  A W Ashton; R Yokota; G John; S Zhao; S O Suadicani; D C Spray; J A Ware
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

2.  Intercellular electrical communication among smooth muscle and endothelial cells in guinea-pig mesenteric arterioles.

Authors:  Y Yamamoto; M F Klemm; F R Edwards; H Suzuki
Journal:  J Physiol       Date:  2001-08-15       Impact factor: 5.182

3.  Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy.

Authors:  M H Beauchamp; A K Martinez-Bermudez; F Gobeil; A M Marrache; X Hou; G Speranza; D Abran; C Quiniou; P Lachapelle; J Roberts; G Almazan; D R Varma; S Chemtob
Journal:  J Appl Physiol (1985)       Date:  2001-06

4.  High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells.

Authors:  Ming-Hui Zou; Chaomei Shi; Richard A Cohen
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

5.  Activation of endothelial cell IK(Ca) with 1-ethyl-2-benzimidazolinone evokes smooth muscle hyperpolarization in rat isolated mesenteric artery.

Authors:  S D Walker; K A Dora; N T Ings; G J Crane; C J Garland
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

6.  Reversal of angiogenesis in vitro, induction of apoptosis, and inhibition of AKT phosphorylation in endothelial cells by thromboxane A(2).

Authors:  Y Gao; R Yokota; S Tang; A W Ashton; J A Ware
Journal:  Circ Res       Date:  2000-10-27       Impact factor: 17.367

7.  Hyperpolarisation of rat mesenteric endothelial cells by ATP-sensitive K(+) channel openers.

Authors:  R White; C R Hiley
Journal:  Eur J Pharmacol       Date:  2000-06-02       Impact factor: 4.432

8.  Characterization of an apamin-sensitive small-conductance Ca(2+)-activated K(+) channel in porcine coronary artery endothelium: relevance to EDHF.

Authors:  M P Burnham; R Bychkov; M Félétou; G R Richards; P M Vanhoutte; A H Weston; G Edwards
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

9.  Cytochrome P450 2C is an EDHF synthase in coronary arteries.

Authors:  B Fisslthaler; R Popp; L Kiss; M Potente; D R Harder; I Fleming; R Busse
Journal:  Nature       Date:  1999-09-30       Impact factor: 49.962

10.  Dominant role of an endothelium-derived hyperpolarizing factor (EDHF)-like vasodilator in the ciliary vascular bed of the bovine isolated perfused eye.

Authors:  A J McNeish; W S Wilson; W Martin
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

View more
  18 in total

1.  Recycling of the Ca2+-activated K+ channel, KCa2.3, is dependent upon RME-1, Rab35/EPI64C, and an N-terminal domain.

Authors:  Yajuan Gao; Corina M Balut; Mark A Bailey; Genaro Patino-Lopez; Stephen Shaw; Daniel C Devor
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

Review 2.  Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.

Authors:  Ivica Grgic; Brajesh P Kaistha; Joachim Hoyer; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2009-03-19       Impact factor: 8.739

3.  Endothelin-1 shifts the mediator of bradykinin-induced relaxation from NO to H2 O2 in resistance arteries from patients with cardiovascular disease.

Authors:  Thomas M Leurgans; Maria Bloksgaard; Jonathan R Brewer; Luis A Bagatolli; Maise H Fredgart; Kristoffer Rosenstand; Maria L Hansen; Lars M Rasmussen; Akhmadjon Irmukhamedov; Jo Gr De Mey
Journal:  Br J Pharmacol       Date:  2016-04-06       Impact factor: 8.739

Review 4.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

5.  Openers of small conductance calcium-activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arterioles.

Authors:  T Dalsgaard; C Kroigaard; M Misfeldt; T Bek; U Simonsen
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 6.  Regulation of cellular communication by signaling microdomains in the blood vessel wall.

Authors:  Marie Billaud; Alexander W Lohman; Scott R Johnstone; Lauren A Biwer; Stephanie Mutchler; Brant E Isakson
Journal:  Pharmacol Rev       Date:  2014-03-26       Impact factor: 25.468

7.  NFAT regulation of cystathionine γ-lyase expression in endothelial cells is impaired in rats exposed to intermittent hypoxia.

Authors:  Laura V Gonzalez Bosc; Jessica M Osmond; Wieslawa K Giermakowska; Carolyn E Pace; Jennifer L Riggs; Olan Jackson-Weaver; Nancy L Kanagy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-01-27       Impact factor: 4.733

8.  Raised tone reveals ATP as a sympathetic neurotransmitter in the porcine mesenteric arterial bed.

Authors:  Amjad Shatarat; William R Dunn; Vera Ralevic
Journal:  Purinergic Signal       Date:  2014-09-18       Impact factor: 3.765

9.  A mathematical model of vasoreactivity in rat mesenteric arterioles: I. Myoendothelial communication.

Authors:  Adam Kapela; Anastasios Bezerianos; Nikolaos M Tsoukias
Journal:  Microcirculation       Date:  2009-11       Impact factor: 2.628

10.  Evidence against C-type natriuretic peptide as an arterial 'EDHF'.

Authors:  C J Garland; K A Dora
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.